Titan Pharmaceuticals Schedules Conference Call to Review Second Quarter 2012 Financial Results August 8, 2012
Titan Completes Preclinical Study of a Continuous, Dopamine Agonist Treatment for Parkinson's Disease July 9, 2012
Titan Pharmaceuticals Schedules Conference Call to Review First Quarter 2012 Financial Results May 9, 2012
Titan Pharmaceuticals Announces Phase 3 Probuphine(R) Data Presentation at the American Society of Addiction Medicine (ASAM) 43rd Medical-Scientific Conference April 20, 2012
Titan Pharmaceuticals Schedules Conference Call to Review Fourth Quarter and Full Year 2011 Financial Results March 14, 2012
